Paradigm shift: The end of "normal science" in medicine - Understanding function in nutrition, health, and disease

Alternative Therapies in Health and Medicine

Volumn 10, Issue 5, 2004, Pages

  Hyman, Mark ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; FOLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PANTOTHENIC ACID; STATINE DERIVATIVE; THIAMINE; VITAMIN; VITAMIN D;

BIOCHEMISTRY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC DISEASE; CLINICAL TRIAL; DRUG MEGADOSE; EDITORIAL; GENE EXPRESSION; GENETIC PREDISPOSITION; GENOMICS; HEALTH; HISTORY OF MEDICINE; HUMAN; LIFESTYLE; LOW FAT DIET; MALNUTRITION; MEDICINE; NUTRITION; POSTOPERATIVE CARE; SCIENCE; SINGLE NUCLEOTIDE POLYMORPHISM; VITAMIN DEFICIENCY; VITAMIN SUPPLEMENTATION;

ATTITUDE TO HEALTH; DEFICIENCY DISEASES; DIET; EVIDENCE-BASED MEDICINE; FOOD PREFERENCES; HEALTH STATUS; HUMANS; NUTRITION DISORDERS; NUTRITION PHYSIOLOGY; PRIMARY PREVENTION; TRACE ELEMENTS; UNITED STATES; VITAMINS;

EID: 19444375566     PISSN: 10786791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (61)

1. Daren K. Heyland, Should Immunonutrition Become Routine in Critically Ill Patients? A Systematic Review of the Evidence. JAMA. 2001;286:944-953.
2. Kaput, Jim, Nutritional genomics: the next frontier in the post genomic era. Physiol Genomics. 16:166-177, 2004;10.1152
3. Michael Mulle. Nittrigenomics: goals and strategies, Nature Reviews, Genetics. 2003;4:315-322.
4. RD Laing. The Voice of Experience. Pantheon, 1982.
5. Kuhn, T. The Structure of Scientific Revolutions (1962) publ. University of Chicago Press, 1962.
6. Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference, New York, 19-22 June, 1946; signed on 22 July 1946 by the representatives of 61 States (Official Records of the World Health Organization, no. 2, p. 100) and entered into force on 7 April 1948.
7. Ewald, Paul. Plague Time: How Stealth Infections Cause Cancer, Heart Disease, and Other Deadly Ailments. The Free Press.
8. McCully, K, Homocysteine, folate, vitamin B6 and cardiovascular disease. JAMA. 1998;279(5):392-3.
9. Taubes, G. The Soft Science of Dietary Fat. Science. 2001;291:2536-2545.
10. Fletcher SW, Colditz GA. Failure of estrogen plus progestin therapy for prevention. JAMA. 2002;288(3):366-8.
11. Pauling, Linus. How to live longer and feel better, Avon Books, 1986.
12. Encarta World English Dictionary. 1999 Microsoft Corporation. All rights reserved. Developed for Microsoft by Bloomsbury Publishing Plc.
13. Susser, M. Causes of Peptic Ulcer: a Selective Epidemiological Review Journal of Chronic Diseases. 1967;20:435-456.
14. Willett W. Dietary Fat Is Not a Major Determinant of Body Fat MD, DrPH. Am J Med. 2002;113(9B):47S-59S.
15. Yudkin J. Sugar: Chemical, Biological and Nutritional aspects of Sucrose. 1971
16. Yudkin J. Sugar consumption and myocardial infarction. Lancet, 1971; 6;1(7693):296-7.
17. Yudkin J. Dietary factors in arteriosclerosis: sucrose. Lipids. 1978;13(5):370-2.
18. Winitz, M. Effect of dietary carbohydrate on serum cholesterol levels. Arch Biochem Biophys. 1964 Dec;108:576-9.
19. Anna Norhammar, Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet, 2002;359:2140-44
20. Mensink R P. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr. 2003;77:1146-55.
21. Pitkin R. Accuracy of Data in Abstracts of Published Research Articles. JAMA. 1999;281:1110-1111.
22. Starfield B. Is US health really the best in the world? JAMA. 2000 Jul 26; 284(4):483-5. Starfield B. Deficiencies in US medical care. JAMA. 2000 Nov 1;284(17):2184-5.
23. Starfield B. Is US health really the best in the world? JAMA. 2000 Jul 26; 284(4):483-5. Starfield B. Deficiencies in US medical care. JAMA. 2000 Nov 1;284(17):2184-5.
24. Zhan C, Miller M. Excess Length of Stay, Charges, and Mortality Attributable to Medical Injuries During Hospitalization. JAMA. 2003;290:1868-1874.
25. Forth Decennial International Conference on Nosocomial and Healthcare Associated Infections, Morbidity and Mortality Weekly Report (MMWR). 2000;49(7):138.
26. Weinstein RA. Nosocomial Infection Update. Special Issue. Emerging Infectious Diseases. 1998;4(3):1998.
27. Lazarou J, Pomeranz B, Corey P. Incidence of adverse drug reactions in hospitalized patients. JAMA. 1998;279:1200-1205.
28. Barczak CA, Barnett RI, Childs EJ, Bosley LM. Fourth National Pressure Ulcer Prevalence Survey. Advances in Wound Care.1997;10-4.
29. Leape LL. Error in medicine. JAMA. 1994 Dec 21;272(23):1851-7.
30. Brennan TA, Leape LL, Laird NM, Hebert L, Localio AR, Lawthers AG, et al. Incidence of adverse events and negligence in hospitalized patients. N Engl J Med. 1991;324:370-376.
31. US Congressional House Subcommittee Oversight Investigation. Cost and Quality of Health Care: Unnecessary Surgery. Washington, DC: Government Printing Office, 1976.
32. Heaney, R. Long-latency deficiency disease: insights from calcium and vitamin D. Am J Clin Nutr. 2003;78:912-9
33. Fonda, D. Curbing the drug marketers. Time. 2004;40-42
34. Rosenthal MB, Berndt ER, Donohue JM, Frank RG, Epstein AM. Promotion of prescription drugs to consumers, N Engl J Med. 2002 Feb 14;346(7):498-505.45.
35. Wolfe SM. Direct-to-consumer advertising-education or emotion promotion? N Engl J Med. 2002;346(7):524-6.
36. Kassirer JP. Financial Conflicts of Interest in Biomedical Research, N Engl J Med. 1993;329:570-571.
37. Holmer A. Industry Strongly Supports Continuing Medical Education. JAMA, 2001;285:2012-2014.
38. Relman A. Separating Continuing Medical Education From Pharmaceutical Marketing. JAMA. 2001;285:2009-2012.
39. Fisher ES. The Implications of Regional Variations in Medicare Spending. Part 2: Health Outcomes and Satisfaction with Care. Annals of Internal Medicine. 2003;138:288-298.
40. Fisher, ES. Medical Care-Is More Always Better? N Engl J Med. 349;17,2003
41. Lenfant C. Shattuck Lecture: Clinical Research to Clinical Practice -Lost in Translation? N Engl J Med. 2003;349:868-874, Aug 28, 2003
42. McGlynn EA. The Quality of Health Care Delivered to Adults in the United States, N Engl J Med. 2003;348:2635-2645, Jun 26, 2003.
43. GJB van Ommen. The Human Genome Project and the Future of Diagnostics, Treatment and Prevention. Lancet. 1999;354:5-10
44. Ames, B. High dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased Km): relevance to genetic disease and polymorphisms. Am J Clin Nutr. 2002;75:616-58
45. Fairfield K. Vitamins for Chronic Disease Prevention in Adults. Scientific Review. JAMA. 2002;287:3116-3126.
46. Norhammar A. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet. 2002; 359:2140-44.
47. Murat V, Chlamydia pneumoniae as an Emerging Risk Factor in Cardiovascular Disease. JAMA. Dec 2002;288:2724-2731.
48. Gullar L. Mercury, fish oils and the risk of myocardial infarction, N Engl J Med. 2002;347:1747-54.
49. Ridker P. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347:1557-65.
50. Farrell RJ. Current Concepts: Celiac Sprue, N Engl J Med. 2002;346:180-188, Jan 17, 2002.
51. Vasquez A. The Clinical Importance of vitamin D (cholecalciferol): A Paradigm Shift with Implications for All Healthcare Providers. Altern Ther Health Med. 2004. 10(5):28-37.
52. Holick, M. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease and osteoporosis. Am J Cliln Nutr. 2004;79:362-71.
53. Pharmaceutical Patient Compliance and Disease Management. Available at: http://www.PharmaDiseaseManagement.com. Accessed August 2004.
54. Breslow L. From disease prevention to health promotion. JAMA. 1999;281: 1030-1033.
55. Pauling, L. Sickle Cell Anemia, a Molecular Disease. Science New Series. 1949. 110 (2865):543-548.
56. Pauling, L. Orthomolecular Psychiatry. Science New Series. 1968;160(3825):265-71.
57. J. Stampfer and W. C. Willett, Homocysteine and marginal vitamin deficiency. The importance of adequate vitamin intake. JAMA. 1993;270:2726-2727.
58. Ames, B. The Metabolic Tune-Up: Metabolic Harmony and Disease Prevention. J Nutr. 133:1544S-1548S, 2003.
59. Hagen T. Ames B. Feeding acetyl-1-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress. Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):1870-5.
60. Shults CW. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Ann Neurol. 2002; 59(10):1541-50.
61. Beal MF. Bioenergetic approaches for neuroprotection in Parkinson's disease. Ann Neurol. 2003;53 Suppl 3:539-47; discussion S47-8.